In Vivo Activation of Naive CD4+ T Cells in Nasal Mucosa-Associated Lymphoid Tissue following Intranasal Immunization with Recombinant Streptococcus gordonii

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Infection and Immunity

• Publication date

  2006-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.74.5.2760-2766.2006PMID 16622213PMCID PMC1459748
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of a B220+ Lymphoid Cell Subpopulation with Immune Modulatory Functions in Nasal-Associated Lymphoid Tissues

  2005cited by this paper
• Bronchus‐ and nasal‐associated lymphoid tissues

  2005cited by this paper
• Clinical and Microbiological Responses of Volunteers to Combined Intranasal and Oral Inoculation with a Streptococcus gordonii Carrier Strain Intended for Future Use as a Group A Streptococcus Vaccine

  2005cited by this paper
• Nasal lymphoid tissue in the rat

  2004cited by this paper
• NALT- versus PEYER'S-patch-mediated mucosal immunity

  2004influential reference
• Primary induction of CD4 T cell responses in nasal associated lymphoid tissue during group A streptococcal infection

  2004cited by this paper
• Upper Respiratory Tract Immunity

  2003cited by this paper
• Nasal tolerance induces antigen-specific CD4+CD25- regulatory T cells that can transfer their regulatory capacity to naive CD4+ T cells.

  2003cited by this paper
• Membranous Cells in Nasal-Associated Lymphoid Tissue: A Portal of Entry for the Respiratory Mucosal Pathogen Group A Streptococcus 1

  2003influential reference
• Tracking salmonella-specific CD4 T cells in vivo reveals a local mucosal response to a disseminated infection.

  2002cited by this paper
• Nasal-Associated Lymphoid Tissue Is a Mucosal Inductive Site for Virus-Specific Humoral and Cellular Immune Responses1

  2002cited by this paper
• Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface.

  2002cited by this paper
• Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.

  2001cited by this paper
• Isotype-specific Selection of High Affinity Memory B Cells in Nasal-associated Lymphoid Tissue

  2001cited by this paper
• Immunogenicity of the B Monomer ofEscherichia coli Heat-Labile Toxin Expressed on the Surface of Streptococcus gordonii

  2000cited by this paper
• Human Dendritic Cells Are Superior to B Cells at Presenting a Major Histocompatibility Complex Class II-Restricted Heterologous Antigen Expressed on Recombinant Streptococcus gordonii

  2000cited by this paper
• Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution.

  2000cited by this paper
• Antigenicity and Immunogenicity of the V3 Domain of HIV Type 1 Glycoprotein 120 Expressed on the Surface of Streptococcus gordonii

  1999cited by this paper
• Human dendritic cells very efficiently present a heterologous antigen expressed on the surface of recombinant gram-positive bacteria to CD4+ T lymphocytes.

  1999cited by this paper
• Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production.

  1999cited by this paper
• Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity.

  1999cited by this paper
• Engineering the gram-positive cell surface for construction of bacterial vaccine vectors.

  1999cited by this paper
• Intranasal Immunization with Cytotoxic T-Lymphocyte Epitope Peptide and Mucosal Adjuvant Cholera Toxin: Selective Augmentation of Peptide-Presenting Dendritic Cells in Nasal Mucosa-Associated Lymphoid Tissue

  1998cited by this paper
• Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells.

  1998cited by this paper
• Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues.

  1998cited by this paper
• Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal‐associated lymphoid tissues and nasal passage, respectively

  1998cited by this paper
• Vaginal Immunization with Recombinant Gram‐Positive Bacteria

  1998cited by this paper
• Vaginal immunization of Cynomolgus monkeys with Streptococcus gordonii expressing HIV-1 and HPV 16 antigens.

  1998cited by this paper
• Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice.

  1997cited by this paper
• Isolation and characterization of mouse nasal-associated lymphoid tissue.

  1997cited by this paper
• Comparison of murine nasal-associated lymphoid tissue and Peyer's patches.

  1997cited by this paper
• Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina

  1997cited by this paper
• Nasal Lymphoid Tissue (NALT) as a Mucosal Immune Inductive Site

  1997cited by this paper
• Use of adoptive transfer of T‐cell antigen‐receptor‐transgenic T cells for the study of T‐cell activation in vivo

  1997influential reference
• Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

  1997cited by this paper
• Recombinant Gram-positive bacteria as vehicles of vaccine antigens

  1997cited by this paper
• A host-vector system for heterologous gene expression in Streptococcus gordonii.

  1996cited by this paper
• Induction of antibody‐secreting cells and T‐helper and memory cells in murine nasal lymphoid tissue

  1996cited by this paper
• Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant

  1996cited by this paper
• Adjuvanticity and protective immunity elicited by Bordetella pertussis antigens encapsulated in poly(DL-lactide-co-glycolide) microspheres

  1995cited by this paper
• Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization.

  1995cited by this paper
• Cholera toxin B stimulates systemic neutralizing antibodies after intranasal co-immunization with measles virus.

  1995cited by this paper
• Immunization of mice by oral colonization with live recombinant commensal streptococci.

  1995cited by this paper
• Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii.

  1994cited by this paper
• Determination of lymphocyte division by flow cytometry.

  1994cited by this paper
• Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi

  1994cited by this paper
• Suppression of the immune response by nasal immunization.

  1994cited by this paper
• Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit

  1993cited by this paper
• The role of nasopharyngeal lymphoid tissue.

  1992cited by this paper
• Method and parameters for genetic transformation of Streptococcus sanguis Challis.

  1990cited by this paper
• Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo.

  1990cited by this paper
• Comparison of intranasal inoculation of influenza HA vaccine combined with cholera toxin B subunit with oral or parenteral vaccination.

  1990cited by this paper
• Antigen recognition by H-2-restricted T cells. II. A tryptic ovalbumin peptide that substitutes for processed antigen.

  1984influential reference
• The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype

  1984cited by this paper
• The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product

  1983cited by this paper
• The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody

  1983cited by this paper

• Nanovaccines: A game changing approach in the fight against infectious diseases.

  2023cites this paper
• Characterization of nanoparticles-based vaccines for COVID-19

  2022cites this paper
• Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology

  2020cites this paper
• Estradiol Enhances Antiviral CD4+ Tissue-Resident Memory T Cell Responses following Mucosal Herpes Simplex Virus 2 Vaccination through an IL-17-Mediated Pathway

  2020cites this paper
• Elucidating the Immune-Related Mechanisms by Which Probiotic Strain Lactobacillus casei BL23 Displays Anti-tumoral Properties

  2019cites this paper
• Long-lasting protective immunity against H7N9 infection is induced by intramuscular or CpG-adjuvanted intranasal immunization with the split H7N9 vaccine.

  2019cites this paper
• Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System

  2018cites this paper
• Non-invasive administration of biodegradable nano-carrier vaccines.

  2017cites this paper
• Modulation of Primary Immune Response by Different Vaccine Adjuvants

  2016cites this paper
• A Stochastic Model for CD 4 + T Cell Proliferation and Dissemination Network in Primary Immune

  2015cites this paper
• A Stochastic Model for CD4+ T Cell Proliferation and Dissemination Network in Primary Immune Response

  2015cites this paper
• Characterization of the Antigen-Specific CD4+ T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous Routes

  2015cites this paper
• Peptide-specific T helper cells identified by MHC class II tetramers differentiate into several subtypes upon immunization with CAF01 adjuvanted H56 tuberculosis vaccine formulation.

  2015cites this paper
• Vaginal Immunization to Elicit Primary T-Cell Activation and Dissemination

  2013cites this paper
• Identification of a branching process model for adaptive immune response

  2013cites this paper
• Prime-Boost Strategies in Mucosal Immunization Affect Local IgA Production and the Type of Th Response

  2013cites this paper
• CD4+ T Cell Priming as Biomarker to Study Immune Response to Preventive Vaccines

  2013cites this paper
• Immunoprotection assays against rat dental caries using Streptococcus sobrinus virulence-associated immunomodulatory protein as a trget antigen.

  2011cites this paper
• Development of adenoviral vector-based mucosal vaccine against influenza

  2011cites this paper
• Development of mucosal vaccines for avian influenza A virus composed of recombinant Lactococcus lactis and Streptococcus gordonii

  2011cites this paper
• Mucosal adjuvants.

  2010cites this paper
• Intranasal immunization with vaccine vector Streptococcus gordonii elicits primed CD4+ and CD8+ T cells in the genital and intestinal tracts.

  2010cites this paper
• Factors mediating successful oral vaccination with lipid-encapsulated Mycobacterium bovis BCG

  2010cites this paper
• Probing local innate immune responses after mucosal immunisation

  2010cites this paper
• Development of antigen-specific T cells in mediastinal lymph nodes after intranasal immunization.

  2009cites this paper
• The European effort towards the development of mucosal vaccines for poverty-related diseases.

  2009cites this paper
• Adoptive transfer of transgenic T cells to study mucosal adjuvants.

  2009cites this paper
• Intranasal administration of the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei with the modified heat-labile toxin of Escherichia coli (LTK63) induces a complete protection against malaria challenge.

  2009cites this paper
• Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS.

  2009cites this paper
• Intranasal immunization of mice with recombinant Streptococcus gordonii expressing NadA of Neisseria meningitidis induces systemic bactericidal antibodies and local IgA.

  2008cites this paper
• Primary Activation of Antigen-Specific Naive CD4+ and CD8+ T Cells following Intranasal Vaccination with Recombinant Bacteria

  2008cites this paper
• Neutrophil-Toxin Interactions Promote Antigen Delivery and Mucosal Clearance of Streptococcus pneumoniae1

  2008cites this paper
• Intranasal vaccines for protection against resipratory and systemic bacterial infections

  2007cites this paper
• Stimulation of Human Monocytes with the Gram-Positive Vaccine Vector Streptococcus gordonii

  2006cites this paper